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Abstract Benzimidazoles are widely used as anthelmintic 
agents and systemic fungicides. In susceptible organisms, 
benzimidazoles bind to P_tubulin and block microtubule poly- 
merization. To further characterize this interaction, sitedirected 
mutagenesis followed by gene replacement was used to change 
Succhuromyces cerevisiue P-tubulin residue Phe-167 to Tyr. 
Consistent with previous studies, this mutation resulted in at least 
34fold decreased sensitivity to the benzimidazole derivatives 
carbendazim and nocodazole. The Tyr-167 mutant was cold 
sensitive, implying a direct effect on benzimidazole binding 
rather than a nonspecific increase in microtubule stability. 
Surprisingly, the mutant had &fold increased sensitivity to the 
derivative benomyl, which is structurally identical to carbenda- 
zim except at position 1. This suggests that residue 167 interacts 
with benzimidazoles in the vicinity of the l-position. 
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1. Introduction 
The benzimidazole derivative thiabendazole was introduced 
in the early 1960s as an anthelmintic agent [l], and soon 
shown to possess antifungal activity as well [2]. Subsequently, 
a series of benzimidazole derivatives with varying substitu- 
tions at the 1, 2 and 5 positions (Fig. 1) were commercially 
developed as human and veterinary anthelmintics (e.g. meben- 
dazole and albendazole) and as agricultural fungicides (beno- 
my1 and carbendazim) [3-51. With one exception (nocodazole), 
benzimidazoles are selectively toxic to lower eukaryotes, in- 
cluding certain protozoa [6]. However, there is wide variation 
in the activity of different derivatives against susceptible or- 
ganisms. For example, the protozoan Trichomonas vaginalis is 
about lOO-fold more sensitive to mebendazole than to beno- 
my1 [6,7], while the reverse is true for the yeast Saccharomyces 
cerevisiae (Li, unpublished data). 
Biochemical and genetic analyses have identified microtu- 
bules as the primary benzimidazole target, specifically the /3- 
tubulin subunit [4,5]. Studying the amino acid changes in 
fungal mutants with altered benzimidazole sensitivity provides 
potentially useful information about benzimidazole-tubulin 
interaction. Mutations in j3-tubulin residues 241 (Arg to 
His) and 167 (Phe to Tyr) conferring benomyl resistance 
were identified in, respectively, S. cerevisiae [8] and Neuro- 
spora crassa [9]. A more extensive analysis of benomyl-resist- 
ant Aspergillus nidulans identified mutations in residues 6, 198 
and 200 [lo]. A mutation in A. niduluns P-tubulin residue 165 
(Ala to Val) conferred resistance to thiabendazole [ll]. How- 
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ever, this mutant was supersensitive to benomyl, carbendazim 
and nocodazole. In aqueous solution, benomyl breaks down 
to carbendazim with a half-life of approx. 1 h [12]. Since 
thiabendazole and carbendazim differ only at their 2 positions 
(Fig. l), Jung and Oakley [ll] deduced that this position in- 
teracts with residue 165. In the work reported here, site-di- 
rected mutagenesis and gene replacement were employed to 
change the P-tubulin residue 167 from Phe to Tyr in S. cere- 
visiae. Analogous to the N. crassa mutant [9], the S. cerevisiae 
mutant was resistant to carbendazim and nocodazole, but 
surprisingly was supersensitive to benomyl. A specific interac- 
tion between residue 167 and benzimidazole compounds is 
suggested by these results. 
2. Materials and methods 
S. cerevisiae strain W303-1A was obtained from Dr. Alan Hudson 
(Medical College of Pennsylvania and Hahnemann University). The 
plasmid pCT-OIL, a pUCl8 derivative containing a complete S. 
cerevisiae P-tubulin gene with a LEU2 gene inserted downstream 
[13], was a gift from Dr. Seiji Matsumoto (Tokyo Metropolitan In- 
stitute of Medical Science, Japan). A full length S. cerevisiae P-tubulin 
gene was amplified by PCR and cloned into M13. Single stranded 
DNA was prepared following growth in dut-, ung- E. coli strain 
CJ236 [14]. A phosphorylated mutagenic oligonucleotide substituting 
TAC (Tyr) for TTC (Phe) in codon 167 was annealed to this DNA 
and extended by incubation with T4 DNA polymerase plus dNTPs. 
Following ligation with T4 DNA ligase, the mutagenized DNA was 
transformed into E. coli XLl-Blue. The presence of the expected mu- 
tation and the absence of any additional mutations were confirmed by 
DNA sequencing. An XbaI-Hind111 fragment (encoding P-tubulin res- 
idues 68 to 393) was subcloned from Ml3 RF DNA into XbaI-Hin- 
dII1 cleaved pCT-OIL, generating pCT-OlLl67Y. This plasmid was 
linearized by digestion with ScaI and BarnHI, and used to transform 
S. cerevisiae W303-1A by the lithium acetate method [15]. Transfor- 
mants were selected on leu- plates at 3O”C, then restreaked on fresh 
leu- plates to obtain pure colonies. 
To prepare genomic DNA, cells were grown in 2 ml YPD (1% yeast 
extract, 1% peptone, 2% dextrose) overnight, and collected by centri- 
fugation. Following 1 min vortexing with glass beads, the cells were 
treated with proteinase K plus sodium dodecyl sulfate at 37°C for 2 h. 
After phenol extraction, DNA was precipitated twice with ethanol. 
Southern blot analysis of NcoI-digested genomic DNA was performed 
by standard procedures [16]. The blots were probed under stringent 
conditions with a 32P-labelled S. cerevisiae P-tubulin gene fragment. 
For selected transformants, P-tubulin gene fragments were amplified 
by PCR, gel purified, and cloned into Ml3. Transformants possessing 
the desired mutation at residue 167, as well as transformants with 
wild-type sequence, were identified by sequencing. 
The sensitivities of selected transformants towards different benzi- 
midazoles (dissolved in dimethyl sulfoxide) were determined by serial 
dilution in YPD medium. Cultures (1 x lo4 cells/ml) were incubated at 
30°C for 18 h, the cell numbers were determined in a hemocytometer, 
and drug concentrations inhibiting growth 50% (I(&) were estimated. 
Sensitivities were also determined towards freshly diluted benomyl, 
and benomyl that was preincubated in YPD at 30°C for I2 h. Growth 
rates at 14, 30, and 37°C were determined by counting the cells every 
2 h, starting at I x lo4 cells/ml. Average cell division times during log 
phase were then estimated. 
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3. Results 
3.1. Site-directed mutagenesis of S. cerevisiae P-tub&n 
Orbach et al. [9] isolated a spontaneous benomyl resistant 
mutant of the filamentous fungus Neurospora crussa and dem- 
onstrated that resistance was due to a change in residue 167 
from Phe to Tyr. To examine the generality of this result and 
to study the phenotype of this mutation more closely, the 
identical change was introduced into a cloned copy of the 
P-tubulin gene from the yeast S. cerevisiae. Following trans- 
formation, genomic DNA was prepared from leu+ colonies. 
As shown in Fig. 2, Southern blot analysis identified several 
transformants with the expected change in P-tubulin band 
size, indicating gene replacement through homologous recom- 
bination. The fi-tubulin genes from four of these transform- 
ants were amplified, cloned, and sequenced. Two of the trans- 
formants (designated WLl67Y) included the desired mutation 
of residue 167, and two (designated WL167F) were wild type 
due to recombination occurring downstream of codon 167. 
Sequencing of the entire WL167Y P-tubulin gene confirmed 
that only codon 167 was mutated. 
3.2. Benzimidazole sensitivities 
The sensitivities of the S. cerevisiae parent (W303-1A) and 
recombinant strains were determined for the benzimidazole 
derivatives carbendazim, nocodazole, thiabendazole, and be- 
nomyl (Table 1). Structurally, nocodazole differs from carben- 
dazim only at the 5-position, thiabendazole differs from car- 
bendazim only at the 2-position, and benomyl differs from 
carbendazim only at the l-position (Fig. 1). The mutant strain 
WL167Y was at least 4-fold less sensitive to nocodazole and 
at least 3-fold less sensitive to carbendazim compared to both 
the parent strain W303-1A and the transformant with the 
wild-type sequence WL167F (the actual reductions in sensitiv- 
ity could not be determined due to limitations in the aqueous 
solubility of nocodazole and carbendazim). There was negli- 
gible difference in the sensitivity of the three strains to thia- 
bendazole. Surprisingly, with respect to benomyl, WL167Y 
was &fold more sensitive than W303-1A and WL167F. Simi- 
lar results were obtained for an additional pair of WL167Y 
and WL167F isolates. 
3.3. Effects of temperature on growth rate 
The growth rates of strains W303-lA, WLl67Y, and 
WL167F were determined at 14, 30 and 37°C in drug-free 
medium. All three strains divided approximately every 2 h 
at 30 and 37’C. At 14°C W303-1A and WL167F division 
time increased to 6-8 h, but the effect on WLl67Y growth 
was more pronounced, with a division time of more than 48 h. 
Thus, WLl67Y is cold-sensitive. 
3.4. Effects of preincubation on benomyl activity 
Benomyl breaks down spontaneously to carbendazim with 
a half-life of approx. 1 h [12]. Indeed, the antimicrotubule 
activity of benomyl is widely attributed to carbendazim alone ; 
i.e. benomyl is considered a prodrug [5]. In light of this, it was 
important to confirm that benomyl was responsible for 
WLl67Y supersensitivity. The sensitivities of strains W303- 
lA, WL167Y and WLl67F were tested in parallel using be- 
nomyl and carbendazim that was either freshly diluted (from 
dimethyl sulfoxide) or preincubated in YPD for 12 h at 30°C. 
For carbendazim, there were no apparent differences. An I& 
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Fig. 1. Structures of (a) benzimidazole, and benzimidazole deriva- 
tives (b) carbendazim, (c) benomyl, (d) nocodazole, and (e) thiaben- 
dazole. 
of 6.5 @ml was obtained in this experiment for strains W303- 
1A and WL167F using both fresh and preincubated carben- 
dazim, while the ICss for WLl67Y remained over 10 &ml in 
both cases. For benomyl, however, a clear difference was ob- 
served. With freshly diluted benomyl the ICsO for WLl67Y 
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was 0.15 kg/ml, while with preincubated benomyl the IC5a 
increased to 6.4 @ml. For W303-1A and WL167F, the be- 
nomyl ICss increased from 1.0 to 6.6 kg/ml with preincuba- 
tion. 
4. Discussion 
There were several reasons for selecting P-tubulin residue 
Phe-167 for analysis by site-directed mutagenesis. First, Or- 
bath et al. [9] previously identified the mutation Phe-167 to 
Tyr in the filamentous fungus N. crassa following selection for 
resistance to the benzimidazole derivative benomyl. However, 
Phe-167 is conserved in nearly all P-tubulins, from both ben- 
zimidazole sensitive and resistant organisms. Furthermore, the 
protozoan Trichomonas vaginalis is highly sensitive to certain 
benzimidazole derivatives [6], and yet its P-tubulin has Tyr- 
167 [7]. Thus, one goal was to resolve these apparent incon- 
sistencies regarding the role of residue 167 in benzimidazole 
sensitivity by studying the phenotype of Tyr-167-substituted 
/3-tubulin in the well defined organism S. cerevisiae. A second 
reason for studying this mutation was its proximity to residue 
165, which has been implicated in the binding of the 2 posi- 
tion side chain of benzimidazoles. Specifically, the mutation 
Ala-165 to Val in the filamentous fungus Aspergillus nidulans 
resulted in thiabendazole resistance but carbendazim super- 
sensitivity [l 11. Since these two derivatives differ only in their 
2 position, it was deduced that this position interacts with 
residue 165. A third reason is that residues 155 to 174 repre- 
sent one of three peptides implicated in GTP binding by UV- 
crosslinking studies [17-191. Two GTP molecules per tubulin 
dimer are required for microtubule assembly. One GTP binds 
to a-tubulin, while the other binds to an ‘exchangeable’ site 
on P-tubulin and, unlike the a-tubulin GTP, undergoes hy- 
drolysis following microtubule assembly [20]. However, in 
binding studies with mammalian tubulin, benzimidazoles 
(i.e. nocodazole) and GTP did not compete with each other 
[5]. Finally, P-tubulin residue 167 was of interest because it 
borders a hydrophilic region which is reactive with antibody 
[21]; thus, it is on or near the microtubule surface. This would 
facilitate its interaction not only with GTP or benzimidazoles, 
but also potentially with other cellular proteins. For example, 
residue Thr-166 represents a potential phosphorylation site 
[22], and hence a potential target for regulators of microtubule 
stability or function. 
The site-directed mutagenesis of S. cerevisiae P-tubulin res- 
idue Phe-167 to Tyr resulted in at least 34-fold decreased 
sensitivity to the benzimidazole derivatives carbendazim and 
nocodazole (Table 1). This result is consistent with the N. 
crassa study, in which this mutation was identified following 
Table 1. S. cerevisiae transformants’ benzimidazole sensitivities 
IC50 Wml) 
W303-1A WL16lFa WL167Yh 
Nocodazole 1.3 2.4 > 1oc 
Carbendazim 3.7 3.9 > 10’ 
Benomyl 1.3 0.83 0.11 
Thiabendazole 18 24 17 
RWL167F is a W303-1A leu+ transformant which encodes wild-type 
Phe at residue 167. 
hWL167Y is a W303-1A leu+ transformant which encodes Tyr at 
residue 167. 
“Limit of carbendazim and nocodazole solubility. 
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Fig. 2. Replacement of wild type with mutated B-tubulin gene. 
(a) Chromosomal B-tubulin locus of parent strain W303-1A. (b) 
Scar-BamHI fragment from pCT-OlL167Y which was used for 
transformation. (c) Expected gene arrangement in chromosomal B- 
tubulin locus following pCT-OlL167Y transformation and homolo- 
gous recombination. The expected lengths of NcoI restriction frag- 
ments are indicated (diagrams are not drawn to scale). Mutated re- 
sidue 167 is shown (*). (d) Southern blot of genomic DNAs 
digested with NcoI and probed with a s2P-labelled B-tubulin gene 
fragment. Lane 1 is parent strain W303-1A; lanes 2-8 are pCT- 
OlL167Y transformants. Lanes 2, 3, and 668 represent the expected 
replacement; lanes 4 and 5 represent insertion events that were not 
characterized further. 
selection for benomyl resistance on agar medium [9]. De- 
creased sensitivity or resistance to microtubule-destabilizing 
drugs, such as the benzimidazoles, can result from two types 
of mutations: those that directly affect drug binding, and 
those that increase microtubule stability and hence indirectly 
confer resistance. The cold sensitivity of the Tyr-167 mutant 
implies a less stable microtubule (e.g. low temperatures are 
routinely used to induce depolymerization in microtubule pur- 
10 
ification procedures). Thus, the Tyr-167 mutation most likely 
affects benzimidazole binding directly. 
In contrast to the results reported for N. crussu, the S. 
cerevisiue Tyr-167 mutant was supersensitive to the derivative 
benomyl. This phenotype was only observed in liquid medium 
with benomyl freshly diluted from a dimethylsulfoxide stock. 
This difference can be understood by considering benomyl 
structure and stability. Benomyl differs from carbendazim 
only at the 1 position, in which benomyl is substituted with 
butylcarbamyl (Fig. 1). This side chain is lost by spontaneous 
intramolecular catalysis in aqueous solutions, yielding carben- 
dazim [23]. Since the half-life of benomyl is about 1 h [12] it is 
generally considered a carbendazim prodrug without activity 
of its own. However, the division time for S. cerevisiae in our 
assays was about 2 h; thus, cells were exposed for 1 to 2 cell 
divisions to significant benomyl concentrations. Given the po- 
tentially irreversible (lethal) activity of benzimidazoles [6], this 
length of exposure is sufficient for activity. The observed 
supersensitivity was lost after a 12 h preincubation of the 
benomyl in medium; i.e. with conversion to carbendazim. 
Consequently, we conclude that benomyl supersensitivity re- 
sulted from the interaction of the 1 position butylcarbamyl 
with Tyr-167. In the N. crassa study [9], benomyl was added 
to agar medium prior to pouring, leading to its conversion to 
carbendazim well before the addition of cells. 
An interaction between P-tubulin residue 167 and the ben- 
zimidazole 1 position (either the butylcarbamyl side chain, or 
the imidazole ring itself) coincides well with the earlier con- 
clusion that residue 165 interacts with the 2 position side 
chain [ll]. Our results suggest a plausible although still spec- 
ulative mode1 for benzimidazole interaction with residue 167. 
In this model, the phenyl side chain of Phe-167 forms a hy- 
drophobic bond with the benzimidazole core. When mutated 
to Tyr, this hydrophobic bond is weakened, decreasing benzi- 
midazole binding and sensitivity. On the other hand, the Tyr- 
167 side chain interacts favorably with butylcarbamoyl at the 
benomyl l-position, perhaps through the formation of a hy- 
drogen bond. This enhanced binding generates supersensitiv- 
ity. 
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